Literature DB >> 25847072

Roles of the lateral fenestration residues of the P2X₄ receptor that contribute to the channel function and the deactivation effect of ivermectin.

Chao Gao1, Qiaqia Yu, Huijuan Xu, Longmei Zhang, Jingxin Liu, Yanling Jie, Wenbo Ma, Damien S K Samways, Zhiyuan Li.   

Abstract

P2X receptors are cation-permeable ion channels gated by extracellular adenosine triphosphate (ATP). Available crystallographic data suggest that ATP-binding ectodomain is connected to the transmembrane pore domain by three structurally conserved linker regions, which additionally frame the lateral fenestrations through which permeating ions enter the channel pore. The role of these linker regions in relaying the conformational change evoked by ATP binding of the ectodomain to the pore-forming transmembrane domain has not been investigated systematically. Using P2X4R as our model, we employed alanine and serine replacement mutagenesis to determine how the side chain structure of these linker regions influences gating. The mutants Y54A/S, F198A/S, and W259A/S all trafficked normally to the plasma membrane of transfected HEK293 cells but were poorly responsive to ATP. Nevertheless, the function of the F198A/S mutants could be recovered by pretreatment with the known positive allosteric modulator of P2X4R, ivermectin (IVM), although the IVM sensitivity of this mutant was significantly impaired relative to wild type. The functional mutants Y195A/S, F200A/S, and F330A/S exhibited ATP sensitivities identical to wild type, consistent with these side chains playing no role in ATP binding. However, Y195A/S, F200A/S, and F330A/S all displayed markedly changed sensitivity to the specific effects of IVM on current deactivation, suggesting that these positions influence allosteric modulation of gating. Taken together, our data indicate that conserved amino acids within the regions linking the ectodomain with the pore-forming transmembrane domain meaningfully contribute to signal transduction and channel gating in P2X receptors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25847072      PMCID: PMC4425721          DOI: 10.1007/s11302-015-9448-5

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  35 in total

1.  Polar residues of the second transmembrane domain influence cation permeability of the ATP-gated P2X(2) receptor.

Authors:  K Migita; W R Haines; M M Voigt; T M Egan
Journal:  J Biol Chem       Date:  2001-06-11       Impact factor: 5.157

2.  Amino acid residues involved in gating identified in the first membrane-spanning domain of the rat P2X(2) receptor.

Authors:  L H Jiang; F Rassendren; V Spelta; A Surprenant; R A North
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

Review 3.  Ivermectin for onchocercal eye disease (river blindness).

Authors:  H Ejere; E Schwartz; R Wormald
Journal:  Cochrane Database Syst Rev       Date:  2001

4.  Regulation of GABA(A) receptor dynamics by interaction with purinergic P2X(2) receptors.

Authors:  Amulya Nidhi Shrivastava; Antoine Triller; Werner Sieghart; Isabella Sarto-Jackson
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

5.  Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses.

Authors:  J G Gu; A B MacDermott
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

6.  Gating mechanism of a P2X4 receptor developed from normal mode analysis and molecular dynamics simulations.

Authors:  Juan Du; Hao Dong; Huan-Xiang Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-29       Impact factor: 11.205

7.  Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors.

Authors:  W Nörenberg; H Sobottka; C Hempel; T Plötz; W Fischer; G Schmalzing; M Schaefer
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

8.  ATP mediates fast synaptic transmission in mammalian neurons.

Authors:  R J Evans; V Derkach; A Surprenant
Journal:  Nature       Date:  1992-06-11       Impact factor: 49.962

9.  Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin.

Authors:  Irena Jelínkova; Vojtech Vávra; Marie Jindrichova; Tomas Obsil; Hana W Zemkova; Hana Zemkova; Stanko S Stojilkovic
Journal:  Pflugers Arch       Date:  2008-04-22       Impact factor: 3.657

10.  Crystal structure of the ATP-gated P2X(4) ion channel in the closed state.

Authors:  Toshimitsu Kawate; Jennifer Carlisle Michel; William T Birdsong; Eric Gouaux
Journal:  Nature       Date:  2009-07-30       Impact factor: 49.962

View more
  6 in total

Review 1.  Insights into the channel gating of P2X receptors from structures, dynamics and small molecules.

Authors:  Jin Wang; Ye Yu
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

Review 2.  Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin.

Authors:  I-Shan Chen; Yoshihiro Kubo
Journal:  J Physiol       Date:  2017-11-09       Impact factor: 5.182

3.  P2X4 Receptor in Silico and Electrophysiological Approaches Reveal Insights of Ivermectin and Zinc Allosteric Modulation.

Authors:  Verónica Latapiat; Felipe E Rodríguez; Francisca Godoy; Felipe A Montenegro; Nelson P Barrera; Juan P Huidobro-Toro
Journal:  Front Pharmacol       Date:  2017-12-15       Impact factor: 5.810

Review 4.  P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology.

Authors:  Leanne Stokes; Janice A Layhadi; Lucka Bibic; Kshitija Dhuna; Samuel J Fountain
Journal:  Front Pharmacol       Date:  2017-05-23       Impact factor: 5.810

Review 5.  To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?

Authors:  Leanne Stokes; Stefan Bidula; Lučka Bibič; Elizabeth Allum
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

6.  Structures and pH-sensing mechanism of the proton-activated chloride channel.

Authors:  Zheng Ruan; James Osei-Owusu; Juan Du; Zhaozhu Qiu; Wei Lü
Journal:  Nature       Date:  2020-11-04       Impact factor: 49.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.